Indaptus Therapeutics is trading 10.62% higher at $2.50 in after-hours trading, with no fresh company-specific announcement identified to explain the gain.
- The stock closed at $2.26 on October 7, 2026, after falling 12.74% in the regular session.
- U.S. stocks were lower amid rising Treasury yields, oil prices and attention to Fed minutes, but that market backdrop does not explain the stock’s opposite-direction move.